Propolis heals and protects - both in the hive and within living beings. Previous studies also confirm the effectiveness of its therapeutic properties on mucous linings of the body. Not surprising that its anti-inflammatory effects on gastrointestinal diseases.
Abstract:
Propolis:
The future therapy against Helicobacter pylori-mediated gastrointestinal
diseases
Abstract:
Helicobacter
pylori (H. pylori), which is found in the stomach of approximately 50% of
humans, remains there for almost the entire lifetime of the infected
individual, leading to various gastrointestinal tract-associated disorders
following full-blown infection.
Due to the emergence of antibiotic resistance,
recurrence and high cost of therapy, most antibiotic-based treatment strategies
are not very effective in eradicating H. pylori infections. The quest for an
alternative treatment free of these inconveniences is currently in demand. One
of the important alternatives is propolis, produced by the honeybee Apis
mellifera, which has been used to treat different diseases since it possesses a
wide range of biochemical properties.
Propolis has been reported as a useful therapeutic
regimen against H. pylori, which is an important cause of gastric inflammation,
peptic ulcer, gastric cancer, and lymphomas of mucosa-associated lymphoid
tissues. Apart from propolis, various active compounds of other natural
products have also been confirmed to be effective. This review compiles the
scientific evidence of the role of propolis and other natural products against
H. pylori-associated gastrointestinal tract-related health complexities by
acting as an anti-angiogenic, anti-inflammatory, and antioxidant factor as well
as via modulation of enzymatic activities.
